Suttle, A Benjamin <br/><br/>
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib.  [electronic resource] 

 -  Journal of clinical pharmacology  Apr 2015 
 - 392-400 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1002/jcph.437  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--pharmacokinetics<br/>Cytochrome P-450 CYP2C8 Inhibitors--pharmacology<br/>Cytochrome P-450 CYP3A Inhibitors--pharmacology<br/>Drug Interactions<br/>Female<br/>Gemfibrozil--pharmacology<br/>Humans<br/>Imidazoles--administration & dosage<br/>Ketoconazole--pharmacology<br/>Male<br/>Middle Aged<br/>Oximes--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Warfarin--pharmacokinetics